Clinical review: Impact of statin substitution policies on patient outcomes

Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: A large database analysis of managed care plans in the United States

(2008) JoAnne M. Foody et al.   CLINICAL THERAPEUTICS

Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care

(2008) Carolyn R Harley et al.   EXPERT OPINION ON PHARMACOTHERAPY

Evaluation of the clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a primary care setting: 2 years on

(2008) J. Usher-Smith et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Statins and diabetes – Authors' reply

(2008) Patricia M Kearney et al.   LANCET

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

(2008) Paul M Ridker et al.   NEW ENGLAND JOURNAL OF MEDICINE

The safety of rosuvastatin in comparison with other statins in over 25 000 statin users in the Saskatchewan Health Databases

(2008) Luis Alberto García-Rodríguez et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

The safety of rosuvastatin in comparison with other statins in over 100 000 statin users in UK primary care

(2008) Luis Alberto García-Rodríguez et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Switching Statin Therapy Using a Pharmacist-Managed Therapeutic Conversion Program versus Usual Care Conversion Among Indigent Patients

(2008) Amy E Miller et al.   PHARMACOTHERAPY

Statin Cost-Effectiveness Comparisons Using Real-World Effectiveness Data: Formulary Implications

(2008) Robert L. Ohsfeldt et al.   VALUE IN HEALTH